Core Viewpoint - Passage Bio, Inc. (PASG) shows significant potential for upside, with a mean price target of $59.25 indicating a 731% increase from its current trading price of $7.13 [1] Price Targets and Estimates - The average price target for PASG ranges from a low of $10.00 to a high of $120.00, with a standard deviation of $46.71, suggesting a high variability in analyst estimates [2] - The lowest estimate indicates a potential increase of 40.3%, while the most optimistic estimate suggests a 1583% upside [2] - Analysts' consensus on price targets is often questioned, as they may not accurately reflect future stock prices [3][7] Earnings Estimates and Analyst Agreement - Strong agreement among analysts regarding PASG's ability to report better earnings than previously predicted supports the view of potential upside [4] - The Zacks Consensus Estimate for the current year has increased by 30.3% over the past month, with two estimates revised higher and no negative revisions [12] - PASG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Implications of Price Movement - While the consensus price target may not be a reliable indicator of potential gains, the direction implied by these targets appears to be a useful guide for further research [14]